{
    "clinical_study": {
        "@rank": "151488", 
        "arm_group": [
            {
                "arm_group_label": "Experimental Arm 1", 
                "arm_group_type": "Experimental", 
                "description": "ONO-9054 eye drop solution, 30 \u00b5g/mL (0.003%), once daily in both eyes, for 28 days."
            }, 
            {
                "arm_group_label": "Active Comparator Arm 2", 
                "arm_group_type": "Active Comparator", 
                "description": "Latanoprost eye drop solution, 0.005%, once daily in both eyes for 28 days."
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objectives of this study are to compare the safety, tolerability, and mean\n      change from baseline in diurnal intraocular pressure (IOP) of ONO-9054 30 \u00b5g/mL (0.003%) to\n      latanoprost 0.005% following ocular instillation once every evening for 28 days."
        }, 
        "brief_title": "A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)", 
        "condition": [
            "Ocular Hypertension", 
            "Open Angle-glaucoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle", 
                "Hypertension", 
                "Ocular Hypertension"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female aged 18-85 (inclusive) with confirmed diagnosis of OHT or OAG\n\n          -  Confirmed diagnosis of bilateral OHT or mild to moderate chronic OAG\n\n          -  Able to undergo washout of all ocular drugs\n\n          -  An IOP \u2265 24 mmHg at 8:00 AM and \u2265 21 mmHg at 10:00 AM in at least 1 eye; but < 36\n             mmHg in both eyes at both Day -5 and Day 1\n\n          -  Central corneal thickness 500-620 \u00b5m at screening and Day -5 in both eyes\n\n          -  Best corrected visual acuity (BCVA) of +0.7 Log Mar or better\n\n        Exclusion Criteria:\n\n          -  Any history of severe ocular trauma in either eye at any time\n\n          -  History of angle closure or ocular laser surgery within the past 3 months or any\n             refractive surgery procedure within the past 6 months of Screening Visit in the study\n             eye(s)\n\n          -  Cataracts that prevent observation or photography of the fundus in either eye"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "108", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02083289", 
            "org_study_id": "ONO-9054IOU003"
        }, 
        "intervention": [
            {
                "arm_group_label": "Experimental Arm 1", 
                "intervention_name": "ONO-9054", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Active Comparator Arm 2", 
                "intervention_name": "Latanoprost", 
                "intervention_type": "Drug", 
                "other_name": "Xalatan\u00ae"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Latanoprost"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "ONO-9054", 
            "ocular hypertension (OHT)", 
            "Open angle-glaucoma (OAG)", 
            "Glaucoma", 
            "Eye Diseases", 
            "Mild to moderate"
        ], 
        "lastchanged_date": "June 4, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90048"
                    }, 
                    "name": "Los Angeles Clinical Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mission Hills", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91345"
                    }, 
                    "name": "Mission Hills Clinical Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newport Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92663"
                    }, 
                    "name": "Newport Beach Clinical Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pasadena", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91105"
                    }, 
                    "name": "Pasadena Clinical Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Petaluma", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94954"
                    }, 
                    "name": "Petaluma Clinical Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Morrow", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30260"
                    }, 
                    "name": "Morrow Clinical Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roswell", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30076"
                    }, 
                    "name": "Roswell Clinical Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "New York Clinical Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "High Point", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27262"
                    }, 
                    "name": "High Point Clinical Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cranberry Township", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "16066"
                    }, 
                    "name": "Cranberry Township Clinical Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Philadelphia Clinical Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78731"
                    }, 
                    "name": "Austin Clinical Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A 28-day Double-masked, Randomized, Parallel-group, Active Controlled Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)", 
        "overall_contact": {
            "email": "v-hirani@ono-uk.co.uk", 
            "last_name": "Vashinda Hirani"
        }, 
        "overall_official": {
            "affiliation": "Ono Pharmaceutical Co. Ltd", 
            "last_name": "Ono Pharmaceutical Co., Ltd.", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Mean change in diurnal IOP (average of four time points) from baseline", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "description": "Physical and ocular examinations (tolerability, hyperemia, visual acuity, pupillometry, corneal thickness, aqueous cells and flare), vital signs, and safety laboratory evaluations", 
                "measure": "Evaluating the safety parameters per protocol", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02083289"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Diurnal IOP", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Mean change from baseline in IOP at each measured time point", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Treatment response rates", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Percent change from baseline in IOP at each measured time point", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }
        ], 
        "source": "Ono Pharmaceutical Co. Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ono Pharmaceutical Co. Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}